Mink Therapeutics, Inc.

Benjamin Jacob Wolf

Marc A Van Dijk

Mark A Exley

Sébastien Lalevée

Arthur Andrew Hurwitz

Ekaterina Vladimirovna Breous-Nystrom

Alessandra Franchino

Cornelia Anne Mundt

Volker Seibert

Reed Masakayan

Daniel Leventhal

Mark Adrian Exley

Provided are TCRs (e.g., TCRs that bind to MLL, e.g., TCRs that bind to an MLL phosphopeptide, e.g., TCRs that bind to an MLL phosphopeptide/MHC complex), cells and pharmaceutical compositions comprising these TCRs, nucleic acids encoding these TCRs, expression vectors and host cells for making these TCRs, and methods of treating a subject using these TCRs.

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

Provided are TCRs (e.g., TCRs that bind to NY-ESO-1), cells and pharmaceutical compositions comprising these TCRs, nucleic acids encoding these TCRs, expression vectors and host cells for making these TCRs, and methods of treating a subject using these TCRs.

T cell receptors that bind to NY-ESO-1 and methods of use thereof

Growing community of inventors

Boston, MA, United States of America

Benjamin Jacob Wolf